TERCICA INC

SOUTH SAN FRANCISCO, CA How do I update this listing?

Create Email Alert

Tercica is based out of South San Francisco. Focuses on the development and commercialization of new therapeutics for the treatment of short stature and other related metabolic disorders. The company is in the development stage (June 30, 2005); its product candidate is Increlex, a DNA-derived recombinant human insulin-like growth factor-1.Whalewisdom has at least 31 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.

Contact Info

tercica inc
651 GATEWAY BLVD SUITE 950
SOUTH SAN FRANCISCO CA    94060

Business Phone: 6506244900
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Elevate your investments